The read at a glance
Computed from the FY2024 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -5.27 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -5.18 — no flag raisedOK
- Earnings quality 75/100 — accruals in line with cashOK
Leadership changes
From DNA X, Inc.'s own filings, the day they're filed.
- Mike Mulica · chief executive officer · appointmenteff. 2026-02-09
- Peter Liu · chief executive officer · departureeff. 2026-01-30
- Charles Becher · chief commercial officer · departureeff. 2026-01-29
Latest filings
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-27
- 10-Q · Quarterly report2026-08-19
- 8-K · Company announcement2026-07-02
- 8-K · Company announcement2026-06-04
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about DNA X, Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when DNA X, Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.